Arbor Biotechnologies

Arbor Biotechnologies is a biotechnology company that discovers and develops next-generation gene therapies. It leverages its proprietary machine learning/AI-driven platform to discover and develop next-generation gene therapies. The company initially focuses on liver and central nervous system diseases and has also partnered with Vertex Pharmaceuticals on multiple gene editing and ex vivo cell therapy projects to expand the application scope of its novel nuclease technology.